拱东医疗：预计2025净利润为4400万元到5600万元，收购子公司出现减值迹象

Core Viewpoint - Gongdong Medical expects a significant decrease in net profit for the fiscal year 2025, projecting a decline of 67.37% to 74.36% compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to shareholders of 44 million to 56 million yuan for 2025 [1] - The net profit, excluding non-recurring gains and losses, is expected to be between 54 million and 66 million yuan, reflecting a year-on-year decrease of 60.75% to 67.89% [1] Subsidiary Performance - Trademark Plastics Inc. (TPI), a subsidiary of the company, reported revenue growth; however, its operating performance declined due to fluctuations in shipping prices [1] - The management has preliminarily assessed that the goodwill arising from the acquisition of TPI shows signs of impairment based on its current operating conditions [1] Investment and Losses - The company has increased its investment in Urumqi Jindongsheng Trading Co., Ltd., leading to control over this entity, which constitutes a merger under non-similar control [1] - This investment has resulted in an estimated non-operating loss of approximately 11 million yuan [1]